KYMR Kymera Therapeutics, Inc.
Biotechnology NasdaqGM
Trading Signals (KYMR)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $39.29
- Medium Support $40.77
- Weak Support $42.26
Resistance Levels
- Weak Resistance $45.24
- Medium Resistance $46.73
- Strong Resistance $48.21
Stop Loss Suggestions
- Conservative $47.14
- Moderate $45.98
- Aggressive $47.47
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | SELL |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (KYMR)
Quarterly Outlook :
2025-12-16
Bullish Scenario
from current 21.49%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
2025-12-16
Base Scenario
from current 8.59%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
2025-12-16
Bearish Scenario
from current -17.19%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
Annual Outlook
2025-12-16
Bullish Scenario
from current 42.97%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
2025-12-16
Base Scenario
from current 17.19%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
2025-12-16
Bearish Scenario
from current -34.38%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (22.51) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (55.93) is in bullish territory, indicating upward momentum. MACD line (2.27) is above Signal line (1.91) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 3.76, indicating the average weekly price range.
Technical Analysis (KYMR)
Trend Identification
EMA
Exponential Moving Average
Current price (43.75) is between Short MA (44.97) and Long MA (40.87), or near one of them. This suggests consolidation or mixed signals. Short MA (44.97) is above Long MA (40.87), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (44.97, 40.87, 36.44) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.4200) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). A bearish crossover above the zero line can indicate a reversal from a prior uptrend. Consider this as a potential early sell signal.
ADX
Average Directional Index
ADX (22.66) indicates a developing or weakening trend. -DI (22.70) is above +DI (19.96), suggesting a bearish directional bias. Be cautious with current positions. Monitor for trend continuation or reversal signals.
Momentum Measurement
RSI (2025-12-16)
Relative Strength Index
RSI (46.08) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV (2025-12-16)
On-Balance Volume
OBV (9275401.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-12-16)
Stochastic Oscillator
Stochastics (%K: 17.77, %D: 18.44) are in the oversold zone (below 20). This suggests the asset may be losing downward momentum. No clear bullish or bearish crossover signal currently. The lines are close or moving sideways.
CCI (2025-12-16)
Commodity Channel Index
CCI (-137.72) is below -100. This suggests a strong downward momentum and an oversold condition. Consider buying or looking for long entries cautiously. Confirm with price action; if price is making lower lows, momentum is strong. Look for rallies to enter short.
Volatility Measurement
ATR (2025-12-16)
Average True Range
Current ATR is 1.6600. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-12-16)
Volatility Bands
Current price (43.75) is within the Bollinger Bands (43.16 - 46.79). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (44.97), indicating short-term bearish bias.
Risk Management & Potential Reversals (KYMR)
SAR (2025-12-16)
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 47.14 is 7.75% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
Stochastic (2025-12-16)
Oversold
Stochastic is in oversold territory (17.8). Monitor for potential bullish crossover or movement above 20, which could signal a reversal.
RSI (2025-12-16)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-12-16)
Reversal Perspective
Bands show normal bandwidth. Price is in the lower half of the bands, suggesting a bearish bias.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (KYMR)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Price (T.Rowe) Associates Inc | INSTITUTIONAL | 6702450 | 10.29% | 2025-03-31 |
| Avoro Capital Advisors LLC | INSTITUTIONAL | 6460000 | 9.92% | 2025-03-31 |
| Wellington Management Group, LLP | INSTITUTIONAL | 5996873 | 9.21% | 2025-03-31 |
| Baker Bros. Advisors, LP | INSTITUTIONAL | 5995929 | 9.21% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 5231392 | 8.03% | 2025-03-31 |
| BVF Inc. | INSTITUTIONAL | 5161801 | 7.93% | 2025-03-31 |
| Atlas Venture Life Science Advisors, LLC | INSTITUTIONAL | 4896462 | 7.52% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 4409234 | 6.77% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 4282903 | 6.58% | 2025-03-31 |
| Siren, L.L.C. | INSTITUTIONAL | 3240313 | 4.98% | 2025-03-31 |
| T. Rowe Price New Horizons Fund, Inc. | MUTUALFUND | 3051818 | 4.69% | 2025-03-31 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | MUTUALFUND | 2351428 | 3.61% | 2025-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 1772890 | 2.72% | 2025-03-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | MUTUALFUND | 1435545 | 2.2% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | MUTUALFUND | 1380563 | 2.12% | 2025-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | MUTUALFUND | 1208485 | 1.86% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 1154914 | 1.77% | 2025-04-30 |
| VANGUARD EXPLORER FUND | MUTUALFUND | 1036819 | 1.59% | 2025-01-31 |
| -Price (T.Rowe) New Horizons Trust | MUTUALFUND | 872235 | 1.34% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | MUTUALFUND | 770663 | 1.18% | 2025-03-31 |